Cypress Semiconductor (NASDAQ: CY) reported a 1.3% decline in second-quarter revenues to $532.2 million, hurt by the weakness in the automotive industry. The top-line was, meanwhile, slightly better than the analysts’ projection of $530.89 million.
The Microcontroller and Connectivity Division saw its revenues slide 3.9% year-over-year on the industry headwinds, as well as the US-China trade tensions. The smaller Memory Products Division, meanwhile, declined 30.4%.
Earnings fell to $0.25 per share from $0.33 per share a year ago. The street projection for Q2 earnings was pegged at $0.24 per share.
CY shares were modestly up 0.18% following the announcement of the results. The stock is up 83% in the year-to-date period, thanks to its acquisition by German rival Infineon Technologies
Last month, the San Jose, California-based firm said it would be acquired by semiconductor solutions firm Infineon Technologies for an enterprise value of €9 billion. The deal, which represented a 46% premium to Cypress’s then trading price, was well received by the street.
The transaction would be closed sometime later this year or early next year, meaning this could be the penultimate or final quarterly results.
Due to the acquisition, Cypress said it will not hold an earnings conference call and has suspended the practice of providing forward-looking guidance.
On Tuesday, rival Texas Instruments (NASDAQ: TXN) also reported a 9% decline in revenue and 7% fall in earnings in the second quarter, hurt by the weakness in the automotive industry.
Most Popular
Citigroup set to report Q4 2025 earnings. Here’s what to expect
Citigroup Inc. (NYSE: C) has undergone a sweeping transformation in recent years, emerging as a more streamlined and profitable financial institution. The bank's performance in recent quarters has underscored the
Home Depot (HD), Lowe’s (LOW): Home improvement pressures not expected to abate soon
Home improvement retailers Home Depot (NYSE: HD) and Lowe’s Companies, Inc. (NYSE: LOW) have been facing a challenging operating environment for a while now. The companies have been battling macroeconomic
Earnings Summary: AngioDynamics (ANGO) Q2 FY26 sales increase 8.8%
Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) on Tuesday reported an increase in net sales for the second quarter of fiscal 2026. In Q2, net sales increased 8.8% year-over-year to
Comments
Comments are closed.